Wells Fargo raised the firm’s price target on Axsome Therapeutics (AXSM) to $160 from $140 and keeps an Overweight rating on the shares. The ...

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

Shares in biopharmaceutical group Axsome Therapeutics (AXSM) surged 23% today after it said it had settled a legal dispute ...

The "Obstructive Sleep Apnea - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.This report provides top line data relating to the clinical trials on ...

pixiv Inc. (hereinafter referred to as "pixiv," Office: Shibuya, Tokyo, Representative Director: Yasuhiro Niwa) is excited to announce a logo redesign for its illustration, manga, and novel ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...

Ratings for Axsome Therapeutics (NASDAQ:AXSM) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...